服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Type | Clone No |
| Anti-INSR/CD220 mAbs [Ersodetug Biosimilar] (MABL-4675) | MABL-4675 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-ENTPD1/CD39 mAbs [Emugrobart Biosimilar] (MABL-4649) | MABL-4649 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF1B/TNFR2/CD120b/TNFR80/p75 mAbs [Emunkitug Biosimilar] (MABL-4650) | MABL-4650 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-AXL/UFO mAbs [Enapotamab Biosimilar] (MABL-4651) | MABL-4651 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF12A/CD266/TWEAKR mAbs [Enavatuzumab Biosimilar] (MABL-4652) | MABL-4652 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LAG3/CD223 mAbs [Encelimab Biosimilar] (MABL-4653) | MABL-4653 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PVRL4/Nectin-4 mAbs [Enfortumab Biosimilar] (MABL-4654) | MABL-4654 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD19 mAbs [Englumafusp Biosimilar] (MABL-4655) | MABL-4655 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ADM mAbs [Enibarcimab Biosimilar] (MABL-4656) | MABL-4656 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Enlonstobart Biosimilar] (MABL-4657) | MABL-4657 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-B7H3/CD276 mAbs [Enoblituzumab Biosimilar] (MABL-4658) | MABL-4658 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL9 mAbs [Enokizumab Biosimilar] (MABL-4659) | MABL-4659 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-DLL4 mAbs [Enoticumab Biosimilar] (MABL-4660) | MABL-4660 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB mAbs [Enristomig Biosimilar] (MABL-4661) | MABL-4661 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, na;na |
| Anti-MUC5AC mAbs [Ensituximab Biosimilar] (MABL-4662) | MABL-4662 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Enuzovimab Biosimilar] (MABL-4663) | MABL-4663 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-HIV-1 gp120 mAbs [Elipovimab Biosimilar] (MABL-4633) | MABL-4633 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-SLAMF7/CD319 mAbs [Elotuzumab Biosimilar] (MABL-4634) | MABL-4634 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Elranatamab Biosimilar] (MABL-4635) | MABL-4635 | ELISA, FACS, Functional assay, in vivo binding | G2;G2, Kappa;Kappa |
| Anti-ENTPD1/CD39 mAbs [Eltivutabart Biosimilar] (MABL-4636) | MABL-4636 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn